Marcel Kannekens

TripleMed BV develops solutions for the treatment of aortic aneurysms. Its product NSAR (non-surgical aneurysm repair) fills the aneurysm, this preventing any further blood from entering it, whilst leaving a channel for the blood to flow through to reach the other arteries. The company was founded by Tjeerd Homsma, Brom, De Vries and Jacobs in 2011 and is headquartered in Maastricht, the Netherlands.

TripleMed BV develops solutions for the treatment of aortic aneurysms. Its product NSAR (non-surgical aneurysm repair) fills the aneurysm, this preventing any further blood from entering it, whilst leaving a channel for the blood to flow through to reach the other arteries. The company was founded by Tjeerd Homsma, Brom, De Vries and Jacobs in 2011 and is headquartered in Maastricht, the Netherlands.

TripleMed BV develops solutions for the treatment of aortic aneurysms. Its product NSAR (non-surgical aneurysm repair) fills the aneurysm, this preventing any further blood from entering it, whilst leaving a channel for the blood to flow through to reach the other arteries. The company was founded by Tjeerd Homsma, Brom, De Vries and Jacobs in 2011 and is headquartered in Maastricht, the Netherlands.

TripleMed BV develops solutions for the treatment of aortic aneurysms. Its product NSAR (non-surgical aneurysm repair) fills the aneurysm, this preventing any further blood from entering it, whilst leaving a channel for the blood to flow through to reach the other arteries. The company was founded by Tjeerd Homsma, Brom, De Vries and Jacobs in 2011 and is headquartered in Maastricht, the Netherlands.